SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001213900-23-080496
Filing Date
2023-09-28
Accepted
2023-09-28 16:18:37
Documents
17
Period of Report
2023-09-22
Items
Item 1.02: Termination of a Material Definitive Agreement
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 CURRENT REPORT ea186002-8k_180life.htm   iXBRL 8-K 34235
2 TERMINATION LETTER (OXFORD LICENSE) SEPTEMBER 22, 2023 ea186002ex10-1_180life.htm EX-10.1 14898
7 GRAPHIC ex10-1_001.jpg GRAPHIC 21556
8 GRAPHIC ex10-1_002.jpg GRAPHIC 1898
9 GRAPHIC ex10-1_003.jpg GRAPHIC 1350
  Complete submission text file 0001213900-23-080496.txt   307066

Data Files

Seq Description Document Type Size
3 XBRL SCHEMA FILE atnf-20230922.xsd EX-101.SCH 3787
4 XBRL DEFINITION FILE atnf-20230922_def.xml EX-101.DEF 26629
5 XBRL LABEL FILE atnf-20230922_lab.xml EX-101.LAB 36680
6 XBRL PRESENTATION FILE atnf-20230922_pre.xml EX-101.PRE 25253
11 EXTRACTED XBRL INSTANCE DOCUMENT ea186002-8k_180life_htm.xml XML 5310
Mailing Address 3000 EL CAMINO REAL BLDG 4, STE 200 PALO ALTO CA 94306
Business Address 3000 EL CAMINO REAL BLDG 4, STE 200 PALO ALTO CA 94306 650-507-0669
180 Life Sciences Corp. (Filer) CIK: 0001690080 (see all company filings)

IRS No.: 813832378 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38105 | Film No.: 231289941
SIC: 2834 Pharmaceutical Preparations